Sentiment-Signal
Score-Verlauf (90 Tage)
Stammdaten
Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treatment. The company offers a miniprotein radioconjugate platform to discover and develop radiopharmaceutical therapies that deliver the tumor-killing properties of radioisotopes. It offers Nectin-4, a miniprotein radioconjugate for the treatment of locally advanced or metastatic urothelial cancer. Its products include AKY-1189 to deliver a radioisotope to Nectin-4 expressing tumors for the treatment of metastatic urothelial cancer, breast cancer, NSCLC, colorectal cancer and cervical cancer; and AKY-2519 to deliver radioisotope to B7-H3 CD276 expressing tumors targeting prostate, lung and other solid tumors. The company was formerly known as HotKnot Therapeutics, Inc. and changed its name to Aktis Oncology, Inc. in April 2020. Aktis Oncology, Inc. was incorporated in 2020 and is based in Boston, Massachusetts.
Unternehmen & Branche
| Name | Aktis Oncology, Inc. |
|---|---|
| Ticker | AKTS |
| CIK | 0002035832 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 01021M104 |
|---|---|
| ISIN | US01021M1045 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,01 Mrd. USD |
| Beta | 0,91 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| UBS Group AG | 353,263 | 0 | 353,263 | 6,319,875 | Neu | +100,0% | |
| Nuveen, LLC | 24,468 | 0 | 24,468 | 437,733 | Neu | +100,0% | |
| PNC FINANCIAL SERVICES GROUP, INC. | 6,948 | 0 | 6,948 | 124,300 | Neu | +100,0% | |
| Police & Firemen's Retirement System of New Jersey | 5,530 | 0 | 5,530 | 98,932 | Neu | +100,0% | |
| STRS OHIO | 3,600 | 0 | 3,600 | 64,404 | Neu | +100,0% | |
| Legal & General Group Plc | 1,826 | 0 | 1,826 | 32,740 | Neu | +100,0% | |
| Russell Investments Group, Ltd. | 1,551 | 0 | 1,551 | 27,747 | Neu | +100,0% | |
| SALEM INVESTMENT COUNSELORS INC | 1,000 | 0 | 1,000 | 17,890 | Neu | +100,0% | |
| Sterling Capital Management LLC | 393 | 0 | 393 | 7,031 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-01-12 | Kim Helen Susan | Director, 10% Owner | Open Market Purchase | 22,545 | 18.00 | 405,810.00 | +3,2% | |
| 2026-01-12 | Kim Helen Susan | Director, 10% Owner | Open Market Purchase | 812,455 | 18.00 | 14,624,190.00 | +115,1% | |
| 2026-01-12 | EcoR1 Capital, LLC | Director | Open Market Purchase | 144,443 | 18.00 | 2,599,974.00 | +20,5% | |
| 2026-01-12 | EcoR1 Capital, LLC | Director | Open Market Purchase | 2,077,779 | 18.00 | 37,400,022.00 | +294,5% | |
| 2026-01-12 | Vida Ventures II, LLC | 10% Owner | Open Market Purchase | 22,545 | 18.00 | 405,810.00 | +3,2% | |
| 2026-01-12 | Vida Ventures II, LLC | 10% Owner | Open Market Purchase | 812,455 | 18.00 | 14,624,190.00 | +115,1% | |
| 2026-01-12 | Foley Todd | Director, 10% Owner | Open Market Purchase | 232,870 | 18.00 | 4,191,660.00 | +33,0% | |
| 2026-01-12 | GADICKE ANSBERT | 10% Owner | Open Market Purchase | 1,112,777 | 18.00 | 20,029,986.00 | +157,7% | |
| 2026-01-12 | MPM BIOVENTURES 2018, L.P. | 10% Owner | Open Market Purchase | 1,112,777 | 18.00 | 20,029,986.00 | +157,7% |
Fail-to-Deliver (6 Monate)
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-04-08 | 1.440 | 16,72 | 24.077 |
| 2026-04-07 | 1.802 | 16,37 | 29.499 |
| 2026-04-06 | 5.988 | 17,37 | 104.012 |
| 2026-04-01 | 12.331 | 17,89 | 220.602 |
| 2026-03-31 | 17.716 | 16,54 | 293.023 |
| 2026-03-30 | 11.687 | 15,19 | 177.526 |
| 2026-03-25 | 52.735 | 18,63 | 982.453 |
| 2026-03-24 | 76.605 | 18,18 | 1.392.679 |
| 2026-03-23 | 195.591 | 17,70 | 3.461.961 |
| 2026-03-06 | 51 | 20,54 | 1.048 |
| 2026-03-05 | 974 | 20,85 | 20.308 |
| 2026-03-04 | 135 | 20,22 | 2.730 |
| 2026-03-03 | 1.399 | 20,00 | 27.980 |
| 2026-02-27 | 602 | 19,63 | 11.817 |
| 2026-02-25 | 2.851 | 20,00 | 57.020 |
| 2026-02-24 | 5.761 | 19,43 | 111.936 |
| 2026-02-17 | 14.136 | 17,76 | 251.055 |
Top-Fondshalter
Stand: 31.03.2026
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| UBS Group AG | 353,263 | 6,319,875 | 88.63 |
| Nuveen, LLC | 24,468 | 437,733 | 6.14 |
| PNC FINANCIAL SERVICES GROUP, INC. | 6,948 | 124,300 | 1.74 |
| Police & Firemen's Retirement System of New Jersey | 5,530 | 98,932 | 1.39 |
| STRS OHIO | 3,600 | 64,404 | 0.90 |
| Legal & General Group Plc | 1,826 | 32,740 | 0.46 |
| Russell Investments Group, Ltd. | 1,551 | 27,747 | 0.39 |
| SALEM INVESTMENT COUNSELORS INC | 1,000 | 17,890 | 0.25 |
| Sterling Capital Management LLC | 393 | 7,031 | 0.10 |